Publications

Sattgast LH, Gallo S, Frankenfeld CL, Moshfegh AJ, Slavin M. 2020. Nutritional intake and bone health among adults with probable undiagnosed, untreated celiac disease: What We Eat in American and NHANES 2009–2014. J Am Coll Nutr 39:112–121.

Frankenfeld CL, Menon N, Leslie TF. 2020. Racial disparities in colorectal cancer time-to-treatment and survival time for colorectal tumors and diagnosing hospital cancer-related diagnostic and treatment capabilities. Cancer Epidemiol 65:101684, https://doi.org/10.1016/j.canep.2020.101684.

Menon N, Leslie TF, Frankenfeld CL. 2020. Cancer-related diagnostic and treatment capabilities of hospitals in the context of racial residential segregation. Public Health 182(May):95–101; https://doi.org/10.1016/j.puhe.2020.02.004.

Frankenfeld CL, Wallace TC. 2020. Dietary patterns and nutritional status in relation to consumption of chickpeas and hummus in the U.S. population. Appl Sci 10:7341, https://doi.org/10.3390/app10207341.

Frankenfeld CL. 2020. Isoflavones. In: Tomás-Barberán FA, González-Sarrías A, García-Villalba R (eds), Dietary (Poly)Phenols: Their Metabolism and Health Effects. Wiley, ISBN: 9781119563747.

Perry C, Rish W, Ring C, Mittal L, Harris M. Use of probabilistic risk assessment and physiologically based pharmacokinetic modeling in supporting soil remedial objectives for dioxins and furans at a Canadian site. Poster for Society for Risk Analysis, Virtual Annual Meeting, 2020.

Benson SM, Maskrey JR, Nembhard MD, Unice KM, Shirley MA, Panko JM. 2019. Evaluation of personal exposure to surgical smoke generated from electrocautery instruments: A pilot study. Ann Work Expos Health 63(9):990-1003; doi: 10.1093/annweh/wxz070.

Wikoff DS, Chappell GA, Fitch S, Doepker CL, Borghoff SJ. 2019. Lack of potential carcinogenicity for aspartame – Systematic evaluation and integration of mechanistic data into the totality of the evidence. Food Chem Toxicol 135:110866.

Revollo JR, Dad A, Pearce MG, Mittelstaedt RA, Robison TW, Dobrovolsky VN. 2019. Pig-a mutations in bone marrow erythroblasts of rats treated with 7,12-dimethyl-benz[a]anthracene. Mutat Res 848(Dec):503106; doi: 10.1016/j.mrgentox.2019.503106.

Ramírez-Valle F, Adams M, Beebe L, Chen J, Chuaqui C, Connarn JN, Corin AF, Dingley KH, et al. 2019. A novel MK2 inhibitor for the treatment of ankylosing spondylitis and other inflammatory diseases. Abstract 1536, Annual Meeting of the American College of Rheumatology Conference, Atlanta, GA, November 2019.

Czerkies LM, Finn KL, Kineman BD, Reichert HA, Cohen SS, Carvalho RS. 2019. Use of a partially hydrolyzed 100% whey-based infant formula with Lacrobacillus reuteri in infants with caregiver-perceived intolerance. J Pedat Health Nutr 1(1):19-26; doi: 10.14302/issn.2691-5014.jphn-19-3067.

Purohit A, Jha R, Khalafallah AM, Price C, Rowan NR, Mukherjee D. 2019. Endoscopic endonasal versus transcranial approach to resection of olfactory groove meningiomas: A systematic review. Neurosurg Rev 1–7; https://doi.org/10.1007/s10143-019-01193-2.

Jackson C, Choi J, Price C, Bettegowda C, Lim M, Gallia G, et al. Surg-16. Supratotal versus gross total resection of glioblastoma: A systematic review [poster]. Neuro-oncology, 21(Supp 6), vi243; doi: 10.1093/neuonc/noz175.1017, 2019.

Shah P, White T, Price C, Mukherjee D. Innv-20. A systematic review of tumor treating fields therapy for primary for recurrent and glioblastoma [presentation]. Neuro-oncology, 21(Sup 6):vi134–va135; doi: 10.1093/neuonc/noz175.563, 2019.

Marschke S, Rish W, Mauro J. 2019. Radiation exposures from the beneficial use of alumina production residue. J Air Waste Manag Assoc 69)12):1479-1489; doi: 10.1080/10962247.2019.1670281.

Chappell GA, Borghoff SJ, Pham L, Doepker CL, Wikoff DS. 2019. Lack of potential carcinogenicity for sucralose — Systematic evaluation and integration of mechanistic data into the totality of the evidence. Food Chem Toxicol 135:110898.

Bylsma LC, Ording AG, Rosenthal A, Öztürk B, Fryzek JP, Arias JM, Röth A, Berentsen S. 2019. Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease. Blood Advances 3(20):2980–2985; doi:10.1182/bloodadvances.2019000476.

Thompson C, Chappell G, Cullen J, Wolf JC, Haws L. Development of an oral reference dose for GenX using the latest toxicological and risk assessment methodologies: Environmental risk assessment of per- and polyfluoroalkyl substances (PFAS). SETAC North America Focused Topic Meeting, Durham, NC, August 2019.

Chappell GA, Thompson CM, Wolf J, Cullen J, Haws LC. Transcriptomic responses in livers of GenX-treated mice demonstrate up-regulation of PPAR signaling and related pathways. Environmental Mutagenesis and Genomics Society, Washington, DC, September 2019.

Thompson CM. The useful chemistry of perfluorinated compounds: Managing safety. The sticky subject of non-stick: Regulatory science challenges of per- and poly-fluorinated compounds (PFAS). Texas A&M University Interdisciplinary Faculty of Toxicology Training Program, 2019 Annual Regulatory Science Symposium, August 2019.